Mirati Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MIRATI THERAPS, and what generic alternatives to MIRATI THERAPS drugs are available?
MIRATI THERAPS has one approved drug.
There is one US patent protecting MIRATI THERAPS drugs.
There are twenty-eight patent family members on MIRATI THERAPS drugs in twenty-eight countries.
Drugs and US Patents for Mirati Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mirati Theraps | KRAZATI | adagrasib | TABLET;ORAL | 216340-001 | Dec 12, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mirati Theraps | KRAZATI | adagrasib | TABLET;ORAL | 216340-001 | Dec 12, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Mirati Theraps | KRAZATI | adagrasib | TABLET;ORAL | 216340-001 | Dec 12, 2022 | RX | Yes | Yes | 10,689,377 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Mirati Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Taiwan | 201938555 | ⤷ Try a Trial |
Brazil | 112020009818 | ⤷ Try a Trial |
South Africa | 202002105 | ⤷ Try a Trial |
Japan | 2021502993 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.